Medications Updated During April 2012, From Newest to Oldest, Page 10

Page 10 of 33 « First Page « … 5 … 8 9 10 11 12 … 15 20 25 30 … » Last Page »

Staxyn (Vardenafil Hydrochloride)

STAXYN(TM) is indicated for the treatment of erectile dysfunction. STAXYN is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction. (1) 2 DOSAGE AND ADMINISTRATION STAXYN is not interchangeable with vardenafil 10…

Physicians Total Care, Inc.23 April 2012

Omeprazole

Omeprazole is a proton pump inhibitor indicated for: Treatment in adults of duodenal ulcer (1.1) and gastric ulcer (1.2) Treatment in adults and children of gastroesophageal reflux disease (GERD) (1.3) and maintenance of healing of erosive…

H.J. Harkins Company, Inc.23 April 2012

Cisplatin

Cisplatin injection is indicated as therapy to be employed as follows: Metastatic Testicular Tumors. In established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors who have already…

Pfizer Laboratories Div Pfizer Inc.21 April 2012

Prochlorperazine Maleate

Prochlorperazine maleate tablets are indicated for the control of severe nausea and vomiting. Prochlorperazine maleate tablets are also indicated for the treatment of schizophrenia. Prochlorperazine is effective for the short-term treatment of…

NCS HealthCare of KY, Inc dba Vangard Labs20 April 2012

Multi-Vit with Fluoride (Dl-alpha-tocoheryl Acetate and Ascorbic Acid and Cholecalciferol and Cyanocobalamin and Niacinamide and Pyridoxine Hydrochloride and Riboflavin and Fluoride and Thiamin Hydrochloride and Vita)

Supplementation of the diet with nine essential vitamins. Supplementation of the diet with fluoride for caries prophylaxis. MULTI-VIT with FLUORIDE 0.25 mg drops were developed to provide fluoride in drop form for infants and young children from 6…

Physicians Total Care, Inc.20 April 2012

Page 10 of 33 « First Page « … 5 … 8 9 10 11 12 … 15 20 25 30 … » Last Page »

FDA Medwatch

CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets
Tue, 07 Jul 2020. As part of CME America's commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard® Infusion Pump Systems, the company conducted additional flow-rate accuracy testing. This testing revealed that some…
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Tue, 07 Jul 2020. Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA,…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.